Claris Biotherapeutics, Inc.
New Filing
CIK: 0001809726·Biotechnology·DELAWARE·Filed: Aug 7, 2026
Total Offering
$121,477,910
Amount Sold
$55,737,646
Investors
14
First Sale
Nov 25, 2025
Offering Details
- Type
- Equity, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Stephen Brady | |
| Reza Dana | |
| Kenneth Harrison | |
| Marc de Garidel | |
| Meredith Fisher | |
| Henry Rath | |
| Susan Orr | |
| Michael Dybbs | |
| Matt Hobson | |
| Maha Radhakrishnan | |
| Clarke Atwell | |
| Brian Baum |
Company
SEC Filing
0001809726-26-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free